Table 2 Patient clinicopathological features
Age, years | 41.63 ± 8.55 |
40 (18 to 67) | |
Disease course, months | 7.71 ± 5.02 |
7 (1 to 26) | |
Sex | |
Male | 286 (59.46) |
Female | 195 (40.54) |
Preoperative steroids | |
No | 160 (33.26) |
Yes | 321 (66.74) |
MGFA class | |
I | 4 (0.83) |
IIA | 108 (22.45) |
IIB | 134 (27.86) |
IIIA | 115 (23.91) |
IIIB | 101 (21.00) |
IVA + IVB + V | 19 (3.95) |
Surgical approach | |
Sternotomy | 437 (90.85) |
VATS | 44 (9.15) |
Postoperative myasthenic crisis | |
No | 441 (91.68) |
Yes | 40 (8.32) |
Masaoka-Koga stage | |
I | 429 (89.19) |
IIa | 21 (4.37) |
IIb | 25 (5.20) |
IIIa | 6 (1.25) |
WHO pathologic type | |
A | 14 (2.91) |
AB | 56 (11.64) |
B1 | 148 (30.77) |
B2 | 173 (35.97) |
B3 | 90 (18.71) |
Tumor size | |
≤ 5 cm | 419 (87.11) |
> 5 cm | 62 (12.89) |
Complete resection | |
No | 16 (3.33) |
Yes | 465 (96.67) |